1h Free Analyst Time
The stem cell banking market is forecasted to grow by USD 8226.74 mn during 2023-2028, accelerating at a CAGR of 11.65% during the forecast period. The report on the stem cell banking market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.Speak directly to the analyst to clarify any post sales queries you may have.
The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by increased federal investment in stem cell therapy, rising prevalence of several chronic disorders, and growing demand for personalized medicines.
The stem cell banking market is segmented as below:
By Product Type
- Adult stem cells
- Umbilical cord blood stem cells
- Embryonic stem cells
By Type
- Private
- Public
By Geographical Landscape
- North America
- Europe
- Asia
- Rest of World (ROW)
The report on the stem cell banking market covers the following areas:
- Stem cell banking market sizing
- Stem cell banking market forecast
- Stem cell banking market industry analysis
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.
The publisher presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research - both primary and secondary. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast the accurate market growth.
Table of Contents
1 Executive Summary
2 Market Landscape
3 Market Sizing
4 Historic Market Size
5 Five Forces Analysis
6 Market Segmentation by Product Type
7 Market Segmentation by Type
8 Customer Landscape
9 Geographic Landscape
10 Drivers, Challenges, and Trends
11 Vendor Landscape
12 Vendor Analysis
13 Appendix
List of Exhibits
Executive Summary
The publisher recognizes the following companies as the key players in the global stem cell banking market: AMS Biotechnology Europe Ltd., CellSave Arabia FZ LLC, Cordlife Group Ltd., CordVida, Cryo Cell International Inc., Cryo Stemcell, Cryoviva Biotech Pvt. Ltd., FUJIFILM Corp., Global Cord Blood Corp., Kids Clinic India Pvt. Ltd., LifeCell International Pvt. Ltd., MEDIPOST Co. Ltd., New England Cord Blood Bank Inc., PerkinElmer Inc., Plus Therapeutics Inc., ReeLabs Pvt. Ltd., Regenerative Medical Services Pvt. Ltd., Smart Cells International Ltd., StemCyte India Therapeutics Pvt. Ltd., and Vita 34 International AG.Commenting on the report, an analyst from the research team said: 'The latest trend gaining momentum in the market is advent of cord blood banking.'
According to the report, one of the major drivers for this market is the increased federal investment in stem cell therapy.
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to a SWOT analysis of the key vendors.
Companies Mentioned (Partial List)
A selection of companies mentioned in this report includes, but is not limited to:
- AMS Biotechnology Europe Ltd.
- CellSave Arabia FZ LLC
- Cordlife Group Ltd.
- CordVida
- Cryo Cell International Inc.
- Cryo Stemcell
- Cryoviva Biotech Pvt. Ltd.
- FUJIFILM Corp.
- Global Cord Blood Corp.
- Kids Clinic India Pvt. Ltd.
- LifeCell International Pvt. Ltd.
- MEDIPOST Co. Ltd.
- New England Cord Blood Bank Inc.
- PerkinElmer Inc.
- Plus Therapeutics Inc.
- ReeLabs Pvt. Ltd.
- Regenerative Medical Services Pvt. Ltd.
- Smart Cells International Ltd.
- StemCyte India Therapeutics Pvt. Ltd.
- Vita 34 International AG